يعرض 1 - 7 نتائج من 7 نتيجة بحث عن '"Barrios, Carlos H."', وقت الاستعلام: 0.93s تنقيح النتائج
  1. 1
    International Association for the Study of Lung Cancer Study of the Impact of Coronavirus Disease 2019 on International Lung Cancer Clinical Trials

    المؤلفون: Smeltzer, Matthew P., Scagliotti V, Giorgio, Wakelee, Heather A., Mitsudomi, Tetsuya, Roy, Upal Basu, Clark, Russell C., Arndt, Renee, Pruett, Clayton D., Kelly, Karen L., Ujhazy, Peter, Johnson, Melissa L., Eralp, Yesim, Barrios, Carlos H., Barlesi, Fabrice, Hirsch, Fred R., Bunn, Paul A., Coronavi, Int Assoc Study Lung Canc, Comm, Clinical Trials Steering

    المساهمون: Acibadem University Dspace, Department of Thoracic Oncology, Università degli studi di Torino = University of Turin (UNITO)-San Luigi Hospital, Aichi Cancer Center Hospital, Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Gustave Roussy (IGR)

    المصدر: JOURNAL OF THORACIC ONCOLOGY
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (5), pp.651-660. ⟨10.1016/j.jtho.2022.01.017⟩

    مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Clinical trials, Telehealth, Lung Neoplasms, Oncology, [SDV]Life Sciences [q-bio], COVID-19, Humans, Lung cancer, Pandemics

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56240aace75cbd5c0fd09bc4353cdbdeTest
    https://doi.org/10.1016/j.jtho.2022.01.017Test


    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1-Selected NSCLC.

    المؤلفون: Jassem, Jacek, de Marinis, Filippo, Giaccone, Giuseppe, Vergnenegre, Alain, Barrios, Carlos H., Morise, Masahiro, Felip, Enriqueta, Oprean, Cristina, Kim, Young-Chul, Andric, Zoran, Mocci, Simonetta, Enquist, Ida, Komatsubara, Kimberly, McCleland, Mark, Kuriki, Hiroshi, Villalobos, Monette, Phan, See, Spigel, David R., Herbst, Roy S.

    المصدر: Journal of Thoracic Oncology; Nov2021, Vol. 16 Issue 11, p1872-1882, 11p

    النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    A Randomized, Double-Blind, Placebo-Controlled, Phase III Noninferiority Study of the Long-Term Safety and Efficacy of Darbepoetin Alfa for Chemotherapy-Induced Anemia in Patients With Advanced NSCLC.

    المؤلفون: Gascón, Pere, Nagarkar, Rajnish, Šmakal, Martin, Syrigos, Konstantinos N., Barrios, Carlos H., Sánchez, Jesús Cárdenas, Zhang, Li, Henry, David H., Gordon, David, Hirsh, Vera, Kubota, Kaoru, Orlov, Sergey, Thomas, Gary, Steinmetz, Tilman, Kang, Jin-Hyoung, Tomita, Dianne K., Fleishman, Alexander N., Park, Joseph K., De Oliveira Brandao, Cisio

    المصدر: Journal of Thoracic Oncology; Feb2020, Vol. 15 Issue 2, p190-202, 13p

    النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية
    P1.45: Impact of Dose Adjustment on Afatinib Safety and Efficacy in EGFR Mutation-Positive NSCLC: Post-Hoc Analyses of LUX-Lung 3/6

    المؤلفون: Barrios, Carlos H., Wu, Yi-Long, Chih-Hsin Yang, James, Sequist, Lecia V., Geater, Sarayut L., Mok, Tony, Hu, Cheng-Ping, Yamamoto, Nobuyuki, O’Byrne, Kenneth, Lu, Shun, Hirsh, Vera, Sebastian, Martin, Okamoto, Isamu, Shah, Riyaz, Märten, Angela, Massey, Dan, Wind, Sven, Schuler, Martin

    المصدر: Journal of Thoracic Oncology; October 2016, Vol. 11 Issue: 10, Number 10 Supplement 1 pS210-S211, 2p

    النص الكامل

    أضف إلى المفضلة
  5. 5
    دورية
    P1.50: Long-Term Safety and Efficacy of Darbepoetin Alfa in Subjects With Advanced Stage NSCLC Receiving Multi-Cycle Chemotherapy

    المؤلفون: Gascón, Pere, Nagarkar, Rajnish, Šmakal, Martin, Syrigos, Kostas, Barrios, Carlos H., Sánchez, Jesús Cárdenas, Zhang, Li, Henry, David H., Fleishman, Alex, De Oliveira Brandao, Cisio

    المصدر: Journal of Thoracic Oncology; October 2016, Vol. 11 Issue: 10, Number 10 Supplement 1 pS214-S215, 2p

    النص الكامل

    أضف إلى المفضلة
  6. 6
    دورية
    P1.33: Afatinib Versus Chemotherapy for EGFR Mutation-Positive NSCLC Patients Aged ≥65 Years: Subgroup Analysis of LUX-Lung 3/6

    المؤلفون: Fein, Luis, Wu, Yi-Long, Sequist, Lecia V., Geater, Sarayut L., Orlov, Sergey, Lee, Ki Hyeong, Tsai, Chun-Ming, Kato, Terufumi, Kiura, Katsuyuki, Barrios, Carlos H., Schuler, Martin, Hirsh, Vera, Yamamoto, Nobuyuki, O’Byrne, Kenneth, Mok, Tony, Massey, Dan, Märten, Angela, Chih-Hsin Yang, James

    المصدر: Journal of Thoracic Oncology; October 2016, Vol. 11 Issue: 10, Number 10 Supplement 1 pS202-S203, 2p

    النص الكامل

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    P1.51: Impact of Regulatory Delays in Drug Approval: Mortality and Morbidity Due to With Lack of Access to Crizotinib in Brazil: Track: Supportive Care and Others.

    المؤلفون: Barrios, Pablo Moura, Debiasi, Marcio, Lopes, Gilberto, Barrios, Carlos H.

    المصدر: Journal of Thoracic Oncology; Oct2016 Supplement, Vol. 11, pS215-S215, 1p

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث